Get the tools used by (smart)2 investors.

Data Explorer for Moberg Pharma AB (publ)

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

MB8: Moberg Pharma AB (publ)

Moberg Pharma AB (publ), a pharmaceutical company, develops and commercializes medical products primarily in Sweden. It develops MOB-015, which has completed Phase III clinical trial for the treatment...

0.67 EUR
Price
EUR
Fair Value
Upside
0.65 - 3.36
52-week range

Analysis

Fiscal Years
Trailing Twelve Months
Fiscal Halfs
Fiscal Quarters
Daily
Hide this widget

The following section summarizes insights on Moberg Pharma AB (publ)'s :

Dec 2016Dec 2018Dec 2020Dec 2022Dec 2024010203040

Performance Summary

    Benchmarks

    Metric Usage

    Hide this widget

    No data available

    Similar Metrics

    Search for metric or datapoint

    Definition

    Hide this widget
    The average price over the last 60 trading days.

    Sector Benchmark Analysis

    Sector
    Industry Group
    Industry
    Hide this widget

    No data available

    All rights reserved. Terms Of Use